Skip to content

Author

B. Van den Eynde

We have 3 of 401 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells.

Therapeutic cancer vaccines are increasingly tested in clinical settings alongside standard-of-care treatments that often include chemotherapy, yet whether chemotherapy synergizes with cancer vaccines remains unclear. Here, we tested heterologous prime-boost viral vector vaccines in combination with various chemotherap...

Laurine Noblecourt, Amanda Wicki, Ashwin K. Jainarayanan et al. · 0 citations
Review Aug 2026

Adrenergic regulation of cancer immunity.

The nervous and immune systems engage in extensive bidirectional crosstalk that shapes tumor progression and therapeutic response. Among the neuro-immune pathways involved in cancer, adrenergic receptor signaling has emerged as a key regulator of the tumor microenvironment. In this review, we summarize current understa...

Jingjing Zhu, Pierre-Hubert Desimpel, C. Gérard et al. · 0 citations
Open access Sep 2026

Thymic age and peripheral residence time determine antitumor competence of CD8+ T cells.

These findings establish developmental imprinting as an important determinant of CD8+ T cell heterogeneity and identify CXCR3+IL-18Rα+ CD8+ T cells as key effectors for antitumor immunity.

Yuan-Qin Yang, Yun-Yi Wang, Amanda Wicki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.